StarD13 differentially regulates migration and invasion in prostate cancer cells

[1]  M. El-Sibai,et al.  Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation , 2020, Cell communication and signaling : CCS.

[2]  M. El-Sibai,et al.  StarD13: a potential star target for tumor therapeutics , 2020, Human Cell.

[3]  M. El-Sibai,et al.  The Role of Rho GTPases in Motility and Invasion of Glioblastoma Cells , 2020, Analytical cellular pathology.

[4]  M. El-Sabban,et al.  Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines , 2019, Cancers.

[5]  G. Zhong,et al.  Long Non-Coding RNA STARD13-AS Suppresses Cell Proliferation And Metastasis In Colorectal Cancer , 2019, OncoTargets and therapy.

[6]  M. El-Sibai,et al.  Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways , 2019, Cells.

[7]  Jing Sun,et al.  High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC , 2019, Molecular medicine reports.

[8]  Yonglian Guo,et al.  Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13 , 2019, Cellular & molecular biology letters.

[9]  Agnieszka Walczak,et al.  Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma , 2019, European journal of histochemistry : EJH.

[10]  V. Lee,et al.  Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma , 2019, Oncogene.

[11]  W. Xu,et al.  RNA‐binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3′UTR with miRNAs , 2018, Cell proliferation.

[12]  Xiaolin Yu,et al.  STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells , 2018, OncoTargets and therapy.

[13]  M. El-Sibai,et al.  Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells , 2018, Analytical cellular pathology.

[14]  Tao Xi,et al.  STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling , 2018, Journal of Hematology & Oncology.

[15]  Tao Xi,et al.  RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network. , 2018, Molecular pharmaceutics.

[16]  W. Muller,et al.  In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors , 2018, Genes, Chromosomes and Cancer.

[17]  Tao Xi,et al.  Displacement of Bax by BMF Mediates STARD13 3'UTR-Induced Breast Cancer Cells Apoptosis in an miRNA-Depedent Manner. , 2018, Molecular pharmaceutics.

[18]  M. Saito,et al.  Downregulation of CD24 suppresses bone metastasis of lung cancer , 2017, Cancer science.

[19]  Tao Xi,et al.  StarD13 3'-untranslated region functions as a ceRNA for TP53INP1 in prohibiting migration and invasion of breast cancer cells by regulating miR-125b activity. , 2018, European journal of cell biology.

[20]  B. Xiong,et al.  Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13. , 2017 .

[21]  Zeeshan Mutahir,et al.  Cancer metastasis - tricks of the trade. , 2017, Bosnian journal of basic medical sciences.

[22]  Y. Miki,et al.  FKBP51 regulates cell motility and invasion via RhoA signaling , 2017, Cancer science.

[23]  Fang Wang,et al.  STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas , 2017, Biotechnology Letters.

[24]  S. Courtneidge,et al.  The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma , 2016, Oncotarget.

[25]  D. Lowy,et al.  DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers , 2016, Oncotarget.

[26]  Mirvat El-Sibai,et al.  Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion. , 2016, International journal of oncology.

[27]  P. Steeg,et al.  Targeting metastasis , 2016, Nature Reviews Cancer.

[28]  Tao Xi,et al.  STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer , 2016, Oncotarget.

[29]  A. Ridley,et al.  Rho GTPase signalling in cell migration , 2015, Current opinion in cell biology.

[30]  C. Siar,et al.  Cellular protrusions--lamellipodia, filopodia, invadopodia and podosomes--and their roles in progression of orofacial tumours: current understanding. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[31]  M. El-Sibai,et al.  Invadopodia, Regulation, and Assembly in Cancer Cell Invasion , 2014, Cell communication & adhesion.

[32]  U. R. Michaelis.  Mechanisms of endothelial cell migration , 2014, Cellular and Molecular Life Sciences.

[33]  E. Diamandis,et al.  Mechanisms of Androgen-Independent Prostate Cancer , 2014, EJIFCC.

[34]  M. El-Sibai,et al.  StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion , 2014, International journal of oncology.

[35]  K. Hahn,et al.  The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. , 2014, Experimental cell research.

[36]  M. El-Sibai,et al.  Effect of StarD13 on colorectal cancer proliferation, motility and invasion. , 2014, Oncology reports.

[37]  M. El-Sibai,et al.  Signaling networks of Rho GTPases in cell motility. , 2013, Cellular signalling.

[38]  J. Alan,et al.  Mutationally activated Rho GTPases in cancer , 2013, Small GTPases.

[39]  M. El-Sibai,et al.  The STAR of the DLC family , 2013, Journal of receptor and signal transduction research.

[40]  M. El-Sibai,et al.  DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma. , 2012, Oncology reports.

[41]  Yi Zheng,et al.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis. , 2011, Cellular signalling.

[42]  Clare M Waterman,et al.  Mechanical integration of actin and adhesion dynamics in cell migration. , 2010, Annual review of cell and developmental biology.

[43]  I. Ng,et al.  Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf‐1–ERK1/2–p70S6K signalling pathway , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[44]  Martin A. Schwartz,et al.  Cell adhesion: integrating cytoskeletal dynamics and cellular tension , 2010, Nature Reviews Molecular Cell Biology.

[45]  Tsutomu Sasaki,et al.  IDENTIFICATION OF THE DELETED IN LIVER CANCER 1 GENE, DLC1, AS A CANDIDATE MENINGIOMA TUMOR SUPPRESSOR , 2008, Neurosurgery.

[46]  Anne J. Ridley,et al.  Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.

[47]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[48]  N. Popescu,et al.  Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. , 2006, International journal of oncology.

[49]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[50]  Alan Hall,et al.  Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.

[51]  J. Segall,et al.  Molecular mechanisms of invadopodium formation: the role of the N-WASP–Arp2/3 complex pathway and cofilin , 2005 .

[52]  I. Pass,et al.  The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion. , 2005, Cold Spring Harbor symposia on quantitative biology.

[53]  P. Abel,et al.  Molecular and cellular biology of prostate cancer , 1997, Cancer and Metastasis Reviews.

[54]  I. Ng,et al.  Deleted in Liver Cancer (DLC) 2 Encodes a RhoGAP Protein with Growth Suppressor Function and Is Underexpressed in Hepatocellular Carcinoma* , 2003, The Journal of Biological Chemistry.

[55]  J. Condeelis,et al.  Cell motility: insights from the backstage , 2002, Nature Cell Biology.

[56]  L. Van Aelst,et al.  The role of Rho GTPases in disease development. , 2002, Gene.

[57]  Tony Hunter,et al.  Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.

[58]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[59]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.